Home/MiNK Therapeutics/Brian Corvese
BC

Brian Corvese

Director

MiNK Therapeutics

MiNK Therapeutics Pipeline

DrugIndicationPhase
MiNK-101Relapsed/Refractory Solid TumorsPhase 1
MiNK-201Acute Respiratory Distress Syndrome (ARDS)Phase 1b/2
CAR-iNKT ProgramsHematological and Solid TumorsPreclinical